Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The anti-borreliae efficacy of phytochemicals and micronutrients: an update.

Goc A, Rath M.

Ther Adv Infect Dis. 2016 Jun;3(3-4):75-82. doi: 10.1177/2049936116655502. Review.

2.

Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.

Pothineni VR, Wagh D, Babar MM, Inayathullah M, Solow-Cordero D, Kim KM, Samineni AV, Parekh MB, Tayebi L, Rajadas J.

Drug Des Devel Ther. 2016 Apr 1;10:1307-22. doi: 10.2147/DDDT.S101486.

3.

Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.

Feng J, Shi W, Zhang S, Zhang Y.

Emerg Microbes Infect. 2015 Jun 3;4:e31. doi: 10.1038/emi.2015.31.

4.

Effectiveness of Stevia Rebaudiana Whole Leaf Extract Against the Various Morphological Forms of Borrelia Burgdorferi in Vitro.

Theophilus PA, Victoria MJ, Socarras KM, Filush KR, Gupta K, Luecke DF, Sapi E.

Eur J Microbiol Immunol (Bp). 2015 Nov 12;5(4):268-80. doi: 10.1556/1886.2015.00031.

5.

Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Magni R, Espina BH, Shah K, Lepene B, Mayuga C, Douglas TA, Espina V, Rucker S, Dunlap R, Petricoin EF, Kilavos MF, Poretz DM, Irwin GR, Shor SM, Liotta LA, Luchini A.

J Transl Med. 2015 Nov 4;13:346. doi: 10.1186/s12967-015-0701-z.

6.

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.

Feng J, Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.

Emerg Microbes Infect. 2014 Jul;3(7):e49. doi: 10.1038/emi.2014.53.

7.

First arrived takes all: inhibitory priority effects dominate competition between co-infecting Borrelia burgdorferi strains.

Devevey G, Dang T, Graves CJ, Murray S, Brisson D.

BMC Microbiol. 2015 Mar 7;15:61. doi: 10.1186/s12866-015-0381-0.

8.

Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline.

Feng J, Auwaerter PG, Zhang Y.

PLoS One. 2015 Mar 25;10(3):e0117207. doi: 10.1371/journal.pone.0117207.

9.

Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States.

Dunn JM, Krause PJ, Davis S, Vannier EG, Fitzpatrick MC, Rollend L, Belperron AA, States SL, Stacey A, Bockenstedt LK, Fish D, Diuk-Wasser MA.

PLoS One. 2014 Dec 29;9(12):e115494. doi: 10.1371/journal.pone.0115494.

10.

An optimized SYBR Green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi.

Feng J, Wang T, Zhang S, Shi W, Zhang Y.

PLoS One. 2014 Nov 3;9(11):e111809. doi: 10.1371/journal.pone.0111809.

11.

Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model.

Hodzic E, Feng S, Barthold SW.

Vector Borne Zoonotic Dis. 2013 Oct;13(10):694-711. doi: 10.1089/vbz.2012.1189.

12.

A probabilistic model in cross-sectional studies for identifying interactions between two persistent vector-borne pathogens in reservoir populations.

Vaumourin E, Gasqui P, Buffet JP, Chapuis JL, Pisanu B, Ferquel E, Vayssier-Taussat M, Vourc'h G.

PLoS One. 2013 Jun 20;8(6):e66167. doi: 10.1371/journal.pone.0066167.

13.
14.

Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2.

Ahangarani RR, Janssens W, Carlier V, Vanderelst L, Vandendriessche T, Chuah M, Jacquemin M, Saint-Remy JM.

Mol Ther. 2011 Apr;19(4):711-22. doi: 10.1038/mt.2010.275.

15.

CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Sahay B, Patsey RL, Eggers CH, Salazar JC, Radolf JD, Sellati TJ.

PLoS Pathog. 2009 Dec;5(12):e1000687. doi: 10.1371/journal.ppat.1000687.

16.

Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells.

Tan D, Goerlitz DS, Dumitrescu RG, Han D, Seillier-Moiseiwitsch F, Spernak SM, Orden RA, Chen J, Goldman R, Shields PG.

Carcinogenesis. 2008 Jun;29(6):1170-7. doi: 10.1093/carcin/bgn034.

17.

Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages.

Lazarus JJ, Kay MA, McCarter AL, Wooten RM.

Infect Immun. 2008 Mar;76(3):1153-62.

18.

Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Salazar JC, Pope CD, Moore MW, Pope J, Kiely TG, Radolf JD.

Clin Diagn Lab Immunol. 2005 Aug;12(8):949-58.

Items per page

Supplemental Content

Support Center